Antibiotic Therapy of Pneumonia in the Obese Patient

Embed Size (px)

Citation preview

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    1/12

    Antibiotic therapy ofpneumonia in the obese

    patient:dosing and delivery

    Muhammad AinulYain

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    2/12

    Purpose of review

    Obesity has been shown to be

    associated with antibioticunderdosing and treatment failure.

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    3/12

    Recent Findings

    Obesity is associated with severalalterations in antibioticpharmacokinetics andpharmacodynamics, includingincreases in the antibiotic volume ofdistribution and clearance.

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    4/12

    Summary

    Recognizing obesity-relatedpharmacokinetic andpharmacodynamic alterations is

    important in treating obese patientswith pneumonia

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    5/12

    Introduction

    Obesity is associated with several alterationsin

    antibiotic pharmacokinetics and

    pharmacodynamics. Data on antibiotic dosing for pneumonia in

    obese patients are limited and come mainlyfrom observational studies.

    Obesity should be considered when dosing ofb-lactams, vancomycin, or aminoglycosidesfor the management of pneumonia.

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    6/12

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    7/12

    RIS FA!"#RS F#R $#SI%&

    !'A%&(S I% #)(S( PA"I(%"S

    Absorption

    Distribution

    etabolism

    Renal clearance !harmacodynamic consideration

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    8/12

    A%"I)I#"I! $#SI%& A%$ $(*I+(RYI%

    #)(S( PA"I(%"S " # lactams

    !iperacillin and tazobactam

    $ephalosoprins

    $arbapenems %luoro&uinolones

    acrolides

    Aminoglycosides

    'ancomycin

    (inezolid

    !olymi)ins Antifungal agents

    *euraminidase inhibitors

    *ebulized antibiotics

    Antibiotic dosing after bariatric+urgery

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    9/12

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    10/12

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    11/12

    F,",R( $IR(!"I#%S !#%!*,SI#%

    Data regarding the dosing of antibiotics inobese patients with pneumonia are limited.

    he correlation between plasma antibiotic

    concen-trations and lung tissue levels inobese patients is lacking and warrantsfurther study.

    %urther studies on the eect of dosing of

    antibiotics in obese patients with pneumoniaon patient-centered out-comes, includingrecovery, relapse, and mortality, are needed

  • 7/26/2019 Antibiotic Therapy of Pneumonia in the Obese Patient

    12/12

    Mercie--